{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:59:05Z","timestamp":1791417545554,"version":"4.3.3"},"reference-count":57,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Microbiology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.tim.2016.06.009","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T13:51:47Z","timestamp":1468677107000},"page":"862-871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":567,"title":["Antibiotic Adjuvants: Rescuing Antibiotics from Resistance"],"prefix":"10.1016","volume":"24","author":[{"given":"Gerard D.","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tim.2016.06.009_bib0290","series-title":"Antibiotic Resistance: Multi-Country Public Awareness Survey","first-page":"51","author":"WHO","year":"2015"},{"key":"10.1016\/j.tim.2016.06.009_bib0295","first-page":"9","article-title":"Insights into newer antimicrobial agents against gram-negative bacteria","volume":"9","author":"Taneja","year":"2016","journal-title":"Microbiol. Insights"},{"key":"10.1016\/j.tim.2016.06.009_bib0300","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1473-3099(15)00500-9","article-title":"Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approach","volume":"16","author":"Rex","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tim.2016.06.009_bib0305","doi-asserted-by":"crossref","first-page":"20140086","DOI":"10.1098\/rstb.2014.0086","article-title":"Time for a change: addressing R&D and commercialization challenges for antibacterials","volume":"370","author":"Payne","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.tim.2016.06.009_bib0310","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1473-3099(12)70293-1","article-title":"A comprehensive regulatory framework to address the unmet need for new antibacterial treatments","volume":"13","author":"Rex","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tim.2016.06.009_bib0315","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1021\/id500052s","article-title":"Solving the Antibiotic Crisis","volume":"1","author":"Wright","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.tim.2016.06.009_bib0320","doi-asserted-by":"crossref","first-page":"10144","DOI":"10.1021\/jm501552x","article-title":"Trends and exceptions of physical properties on antibacterial activity for Gram-positive and Gram-negative pathogens","volume":"57","author":"Brown","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tim.2016.06.009_bib0325","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/acsinfecdis.5b00097","article-title":"Permeability barrier of Gram-negative cell envelopes and approaches to bypass it","volume":"1","author":"Zgurskaya","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.tim.2016.06.009_bib0330","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: confronting the challenges of antibacterial discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.tim.2016.06.009_bib0335","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrd4572","article-title":"ESKAPEing the labyrinth of antibacterial discovery","volume":"14","author":"Tommasi","year":"2015","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.tim.2016.06.009_bib0340","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature17042","article-title":"Antibacterial drug discovery in the resistance era","volume":"529","author":"Brown","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tim.2016.06.009_bib0345","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic resistance-the need for global solutions","volume":"13","author":"Laxminarayan","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tim.2016.06.009_bib0350","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S1473-3099(14)70827-8","article-title":"Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections--needs, advances, and future prospects","volume":"14","author":"Zumla","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tim.2016.06.009_bib0355","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/1751-7915.12044","article-title":"Antibiotic adjuvants: identification and clinical use","volume":"6","author":"Bernal","year":"2013","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.tim.2016.06.009_bib0360","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/cbdd.12478","article-title":"Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens","volume":"85","author":"Gill","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.tim.2016.06.009_bib0365","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1017\/S1462399410001766","article-title":"Antibiotic adjuvants: multicomponent anti-infective strategies","volume":"13","author":"Kalan","year":"2011","journal-title":"Expert. Rev. Mol. Med."},{"key":"10.1016\/j.tim.2016.06.009_bib0370","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1128\/AAC.02231-15","article-title":"Suppression of emergence of resistance in pathogenic bacteria: keeping our powder dry, Part 2","volume":"60","author":"Drusano","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2016.06.009_bib0375","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tibtech.2012.12.006","article-title":"Combination approaches to combat multidrug-resistant bacteria","volume":"31","author":"Worthington","year":"2013","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.tim.2016.06.009_bib0380","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1128\/CMR.1.2.139","article-title":"Antibiotic combinations: should they be tested?","volume":"1","author":"Eliopoulos","year":"1988","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.tim.2016.06.009_bib0385","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1021\/cb400487f","article-title":"Murgocil is a highly bioactive staphylococcal-specific inhibitor of the peptidoglycan glycosyltransferase enzyme MurG","volume":"8","author":"Mann","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.tim.2016.06.009_bib0390","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cels.2015.12.003","article-title":"Prediction of synergism from chemical-genetic interactions by machine learning","volume":"1","author":"Wildenhain","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.tim.2016.06.009_bib0395","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrd4675","article-title":"Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?","volume":"14","author":"Brown","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tim.2016.06.009_bib0400","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/AAC.11.5.852","article-title":"Clavulanic acid: a beta-lactamase-inhibiting beta-lactam from Streptomyces clavuligerus","volume":"11","author":"Reading","year":"1977","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2016.06.009_bib0405","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/AAC.14.5.650","article-title":"Clavulanic acid, a novel inhibitor of beta-lactamases","volume":"14","author":"Neu","year":"1978","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2016.06.009_bib0410","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ijantimicag.2015.08.011","article-title":"A resurgence of beta-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens","volume":"46","author":"Bush","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.tim.2016.06.009_bib0415","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/nyas.12010","article-title":"New beta-lactam-beta-lactamase inhibitor combinations in clinical development","volume":"1277","author":"Shlaes","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tim.2016.06.009_bib0420","doi-asserted-by":"crossref","first-page":"249856","DOI":"10.1155\/2014\/249856","article-title":"Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria","volume":"2014","author":"Dortet","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.tim.2016.06.009_bib0425","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13445","article-title":"Aspergillomarasmine A overcomes metallo-beta-lactamase antibiotic resistance","volume":"510","author":"King","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tim.2016.06.009_bib0430","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1021\/cb3005116","article-title":"Aminoglycoside antibiotics in the 21st century","volume":"8","author":"Becker","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.tim.2016.06.009_bib0435","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.chembiol.2011.10.018","article-title":"A small molecule discrimination map of the antibiotic resistance kinome","volume":"18","author":"Shakya","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tim.2016.06.009_bib0440","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/BJ20130317","article-title":"Structure-guided optimization of protein kinase inhibitors reverses aminoglycoside antibiotic resistance","volume":"454","author":"Stogios","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.tim.2016.06.009_bib0445","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1128\/AAC.22.5.824","article-title":"7-Hydroxytropolone: an inhibitor of aminoglycoside-2\u201c-O-adenylyltransferase","volume":"22","author":"Allen","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2016.06.009_bib0450","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1016\/j.bmcl.2014.09.037","article-title":"Inhibition of the ANT(2\u201d)-Ia resistance enzyme and rescue of aminoglycoside antibiotic activity by synthetic alpha-hydroxytropolones","volume":"24","author":"Hirsch","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tim.2016.06.009_bib0455","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1074-5521(03)00026-7","article-title":"Broad-spectrum peptide inhibitors of aminoglycoside antibiotic resistance enzymes","volume":"10","author":"Boehr","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tim.2016.06.009_bib0460","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nchembio.559","article-title":"Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy","volume":"7","author":"Ejim","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tim.2016.06.009_bib0465","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.chembiol.2013.07.006","article-title":"Collapsing the proton motive force to identify synergistic combinations against Staphylococcus aureus","volume":"20","author":"Farha","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tim.2016.06.009_bib0470","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/cb300413m","article-title":"Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to beta-lactams","volume":"8","author":"Farha","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.tim.2016.06.009_bib0475","doi-asserted-by":"crossref","first-page":"329ra332","DOI":"10.1126\/scitranslmed.aad7364","article-title":"TarO-specific inhibitors of wall teichoic acid biosynthesis restore beta-lactam efficacy against methicillin-resistant staphylococci","volume":"8","author":"Lee","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tim.2016.06.009_bib0480","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.chembiol.2012.11.013","article-title":"Discovery of wall teichoic acid inhibitors as potential anti-MRSA beta-lactam combination agents","volume":"20","author":"Wang","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tim.2016.06.009_bib0485","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1021\/cb300269g","article-title":"A forward chemical screen identifies antibiotic adjuvants in Escherichia coli","volume":"7","author":"Taylor","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.tim.2016.06.009_bib0490","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/jac\/dku057","article-title":"An unusual class of anthracyclines potentiate Gram-positive antibiotics in intrinsically resistant Gram-negative bacteria","volume":"69","author":"Cox","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.tim.2016.06.009_bib0570","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/ml200290p","article-title":"Small molecule suppression of carbapenem resistance in NDM-1 producing Klebsiella pneumoniae","volume":"3","author":"Worthington","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.tim.2016.06.009_bib0495","doi-asserted-by":"crossref","first-page":"11254","DOI":"10.1002\/anie.201206911","article-title":"Potent small-molecule suppression of oxacillin resistance in methicillin-resistant Staphylococcus aureus","volume":"51","author":"Harris","year":"2012","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.tim.2016.06.009_bib0500","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1021\/jm501050e","article-title":"Small-molecule suppression of beta-lactam resistance in multidrug-resistant gram-negative pathogens","volume":"57","author":"Brackett","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tim.2016.06.009_bib0505","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/CMR.00117-14","article-title":"The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria","volume":"28","author":"Li","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.tim.2016.06.009_bib0510","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/AAC.45.1.105-116.2001","article-title":"Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy","volume":"45","author":"Lomovskaya","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2016.06.009_bib0515","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1128\/AEM.07227-11","article-title":"Small-molecule modulators of Listeria monocytogenes biofilm development","volume":"78","author":"Nguyen","year":"2012","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.tim.2016.06.009_bib0520","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1002\/cbic.201100500","article-title":"Palmitoyl-dl-carnitine is a multitarget inhibitor of Pseudomonas aeruginosa biofilm development","volume":"12","author":"Wenderska","year":"2011","journal-title":"Chembiochem."},{"key":"10.1016\/j.tim.2016.06.009_bib0525","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1128\/AAC.03163-14","article-title":"A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms","volume":"58","author":"Reffuveille","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2016.06.009_bib0530","doi-asserted-by":"crossref","first-page":"20321","DOI":"10.1038\/srep20321","article-title":"The quorum sensing inhibitor hamamelitannin increases antibiotic susceptibility of Staphylococcus aureus biofilms by affecting peptidoglycan biosynthesis and eDNA release","volume":"6","author":"Brackman","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tim.2016.06.009_bib0535","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4155\/fmc.15.7","article-title":"Agents that inhibit bacterial biofilm formation","volume":"7","author":"Rabin","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.tim.2016.06.009_bib0540","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2016.02.006","article-title":"New frontiers for anti-biofilm drug development","volume":"160","author":"Ribeiro","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tim.2016.06.009_bib0545","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/AAC.00906-09","article-title":"Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code","volume":"54","author":"Liu","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2016.06.009_bib0550","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1091\/mbc.E15-08-0573","article-title":"A robust platform for chemical genomics in bacterial systems","volume":"27","author":"French","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.tim.2016.06.009_bib0555","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrmicro2745","article-title":"Modulating immunity as a therapy for bacterial infections","volume":"10","author":"Hancock","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tim.2016.06.009_bib0560","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1586\/eri.10.38","article-title":"Synergy among antibacterial peptides and between peptides and small-molecule antibiotics","volume":"8","author":"Cassone","year":"2010","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"10.1016\/j.tim.2016.06.009_bib0565","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ja.2014.83","article-title":"A macrophage-stimulating compound from a screen of microbial natural products","volume":"68","author":"Perry","year":"2015","journal-title":"J. Antibiot. (Tokyo)"}],"updated-by":[{"DOI":"10.1016\/j.tim.2016.07.008","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000}}],"container-title":["Trends in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X16300725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X16300725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:38:27Z","timestamp":1760812707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966842X16300725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0966842X16300725"],"URL":"https:\/\/doi.org\/10.1016\/j.tim.2016.06.009","relation":{},"ISSN":["0966-842X"],"issn-type":[{"value":"0966-842X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic Adjuvants: Rescuing Antibiotics from Resistance","name":"articletitle","label":"Article Title"},{"value":"Trends in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tim.2016.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}